These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 29476865

  • 1. Strategies to improve the regulatory assessment of developmental neurotoxicity (DNT) using in vitro methods.
    Bal-Price A, Pistollato F, Sachana M, Bopp SK, Munn S, Worth A.
    Toxicol Appl Pharmacol; 2018 Sep 01; 354():7-18. PubMed ID: 29476865
    [Abstract] [Full Text] [Related]

  • 2. Current Availability of Stem Cell-Based In Vitro Methods for Developmental Neurotoxicity (DNT) Testing.
    Fritsche E, Barenys M, Klose J, Masjosthusmann S, Nimtz L, Schmuck M, Wuttke S, Tigges J.
    Toxicol Sci; 2018 Sep 01; 165(1):21-30. PubMed ID: 29982830
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Consensus statement on the need for innovation, transition and implementation of developmental neurotoxicity (DNT) testing for regulatory purposes.
    Fritsche E, Grandjean P, Crofton KM, Aschner M, Goldberg A, Heinonen T, Hessel EVS, Hogberg HT, Bennekou SH, Lein PJ, Leist M, Mundy WR, Paparella M, Piersma AH, Sachana M, Schmuck G, Solecki R, Terron A, Monnet-Tschudi F, Wilks MF, Witters H, Zurich MG, Bal-Price A.
    Toxicol Appl Pharmacol; 2018 Sep 01; 354():3-6. PubMed ID: 29447839
    [Abstract] [Full Text] [Related]

  • 5. An industry perspective: A streamlined screening strategy using alternative models for chemical assessment of developmental neurotoxicity.
    Li J, Settivari R, LeBaron MJ, Marty MS.
    Neurotoxicology; 2019 Jul 01; 73():17-30. PubMed ID: 30786249
    [Abstract] [Full Text] [Related]

  • 6. Towards a regulatory use of alternative developmental neurotoxicity testing (DNT).
    Terron A, Bennekou SH.
    Toxicol Appl Pharmacol; 2018 Sep 01; 354():19-23. PubMed ID: 29454059
    [Abstract] [Full Text] [Related]

  • 7. Assessment of developmental neurotoxicity induced by chemical mixtures using an adverse outcome pathway concept.
    Pistollato F, de Gyves EM, Carpi D, Bopp SK, Nunes C, Worth A, Bal-Price A.
    Environ Health; 2020 Feb 24; 19(1):23. PubMed ID: 32093744
    [Abstract] [Full Text] [Related]

  • 8. A better approach to in vivo developmental neurotoxicity assessment: Alignment of rodent testing with effects seen in children after neurotoxic exposures.
    Vorhees CV, Sprowles JN, Regan SL, Williams MT.
    Toxicol Appl Pharmacol; 2018 Sep 01; 354():176-190. PubMed ID: 29544898
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Design and validation of an ontology-driven animal-free testing strategy for developmental neurotoxicity testing.
    Hessel EVS, Staal YCM, Piersma AH.
    Toxicol Appl Pharmacol; 2018 Sep 01; 354():136-152. PubMed ID: 29544899
    [Abstract] [Full Text] [Related]

  • 11. Towards in vitro DT/DNT testing: Assaying chemical susceptibility in early differentiating NT2 cells.
    Menzner AK, Abolpour Mofrad S, Friedrich O, Gilbert DF.
    Toxicology; 2015 Dec 02; 338():69-76. PubMed ID: 26498558
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Recommendation on test readiness criteria for new approach methods in toxicology: Exemplified for developmental neurotoxicity.
    Bal-Price A, Hogberg HT, Crofton KM, Daneshian M, FitzGerald RE, Fritsche E, Heinonen T, Hougaard Bennekou S, Klima S, Piersma AH, Sachana M, Shafer TJ, Terron A, Monnet-Tschudi F, Viviani B, Waldmann T, Westerink RHS, Wilks MF, Witters H, Zurich MG, Leist M.
    ALTEX; 2018 Dec 02; 35(3):306-352. PubMed ID: 29485663
    [Abstract] [Full Text] [Related]

  • 15. International Regulatory and Scientific Effort for Improved Developmental Neurotoxicity Testing.
    Sachana M, Bal-Price A, Crofton KM, Bennekou SH, Shafer TJ, Behl M, Terron A.
    Toxicol Sci; 2019 Jan 01; 167(1):45-57. PubMed ID: 30476307
    [Abstract] [Full Text] [Related]

  • 16. Developmental neurotoxicity of different pesticides in PC-12 cells in vitro.
    Christen V, Rusconi M, Crettaz P, Fent K.
    Toxicol Appl Pharmacol; 2017 Jun 15; 325():25-36. PubMed ID: 28385489
    [Abstract] [Full Text] [Related]

  • 17. Revolutionizing developmental neurotoxicity testing - a journey from animal models to advanced in vitro systems.
    Smirnova L, Hogberg HT, Leist M, Hartung T.
    ALTEX; 2024 Jun 15; 41(2):152-178. PubMed ID: 38579692
    [Abstract] [Full Text] [Related]

  • 18. A perspective on In vitro developmental neurotoxicity test assay results: An expert panel review.
    Juberg DR, Fox DA, Forcelli PA, Kacew S, Lipscomb JC, Saghir SA, Sherwin CM, Koenig CM, Hays SM, Kirman CR.
    Regul Toxicol Pharmacol; 2023 Sep 15; 143():105444. PubMed ID: 37442267
    [Abstract] [Full Text] [Related]

  • 19. An analysis of the limitations and uncertainties of in vivo developmental neurotoxicity testing and assessment to identify the potential for alternative approaches.
    Paparella M, Bennekou SH, Bal-Price A.
    Reprod Toxicol; 2020 Sep 15; 96():327-336. PubMed ID: 32781019
    [Abstract] [Full Text] [Related]

  • 20. Don't judge a neuron only by its cover: neuronal function in in vitro developmental neurotoxicity testing.
    de Groot MW, Westerink RH, Dingemans MM.
    Toxicol Sci; 2013 Mar 15; 132(1):1-7. PubMed ID: 22961093
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.